Bitdoctor hosted a Twitter Space on 25th November 2024, at 3:30 PM UTC. Participants included representatives of BitDoctor.ai (Asher), Muhdo (Nathan), ZayaAI (Mister Spread), BiohackerDAO (Mgoes), and Hippocrat (Justin). The discussion highlighted DeSci (Decentralized Science) as a rapidly rising Web3 narrative, with endorsements from crypto leaders like CZ, Vitalik, and Brian Armstrong.
Asher: Highlighted DeSci’s rise as a narrative that moves Web3 beyond non-utility projects into meaningful applications.
Spread: Noted Web3’s maturing space and leaders seeking legacy-impact projects. He suggested DeSci reflects a broader trend toward serious, purposeful innovation.
Spread: Referenced global trends in health and figures like Bryan Johnson driving the longevity narrative.
Nathan: Stressed that DeSci aligns with the global push for preventative healthcare, blockchain’s transparency, and user-controlled data.
Mgoes: Emphasized how blockchain allows individuals — not just institutions — to invest in early-stage biotech, bypassing restrictive traditional funding.
Asher: Advocated for decentralized research funding to counteract monopolies and facilitate unrestricted innovation.
Nathan: Explained how Web3 introduces transparency in healthcare, enabling individuals to see and control their data. They noted DeSci could bridge gaps between traditional systems and decentralized innovation.
Nathan: Highlighted the importance of patience, as scientific research often requires years to bear fruit, contrasting with their readiness to deliver utility immediately.
Mgoes: Echoed sentiments about DeSci onboarding new participants into crypto, creating use cases that expand Web3’s reach beyond finance.
The second part of the Twitter Space explored whether the DeSci space can drive significant adoption from Web2 to Web3, potentially at a scale similar to DeFi and GameFi. Here’s a concise overview of the key points and perspectives shared by participants:
Spread emphasized that mass adoption requires apps and tools to be seamless and intuitive. He noted that current Web3 tools like MetaMask remain complex for mainstream users.
Zaya.ai is focusing on making its services frictionless, such as enabling users to pay in fiat or crypto without needing to understand the underlying blockchain infrastructure.
Zaya.ai is collaborating with the Indonesian government to eradicate tuberculosis by deploying campaign hospitals and AI-driven diagnostics. This model is intended to scale to India, Africa, and beyond, integrating blockchain without users necessarily being aware of it.
Each diagnostic transaction triggers backend token purchases, creating a practical and scalable Web3 application that drives adoption organically.
Mgoes highlighted that DeSci can appeal to entirely new demographics, such as science enthusiasts or longevity advocates. Projects like BiohackerDAO could draw individuals interested in self-optimization, moving the focus beyond traditional crypto user bases.
Nathan pointed out that health data is deeply personal, and blockchain’s transparency helps build trust. They emphasized rewarding users for sharing health data responsibly, creating an appealing model for both Web2 and Web3 users.
The panel agreed on the role of rewards — be it financial or health-related — in encouraging participation. Projects are striving to make these rewards meaningful and transparent, unlike traditional Web2 loyalty programs.
The DeSci space, much like Play-to-Earn games, has the potential to onboard large numbers of users by providing tangible benefits and tapping into diverse interests like health, longevity, and community-driven research funding.
Justin: Believes retail liquidity will play a crucial role in the growth of DeSci projects, similar to what happened with gaming projects during the last bull market. Explains that during bull markets, it’s retail investors who push prices up, and DeSci has the potential to attract this liquidity once the value proposition is understood by a wider audience.
Mgoes: Stresses the importance of DeSci’s real-world value, but acknowledges that larger market caps will help bring more attention to the sector, which benefits all involved.
Spread: Shares the hope that DeSci projects can reach large valuations, creating a positive impact on the Web3 ecosystem.
Spread: Suggests that DeSci projects could attract long-term investors who believe in their potential, especially as the sector matures, shifting liquidity away from stablecoins and into promising projects with real-world applications.
Mgoes: Points out the growing attention on DeSci projects
Traditional pharma giants like Pfizer, GSK, and AstraZeneca are expected to explore the DeSci space cautiously. They may begin with small, stealth projects rather than large-scale initiatives. These companies often observe the potential of emerging fields before fully committing, akin to how traditional finance eventually embraced decentralized finance (DeFi). The timeline for significant involvement might stretch beyond 12–24 months unless driven by regulatory or technological shifts in key markets like the U.S.
Major medical technology firms such as Leica and Johnson & Johnson are already observing developments in blockchain and DeSci. Tools like Zaya’s AI software, capable of connecting to medical devices via APIs, highlight how blockchain could enhance interoperability in healthcare. However, the bureaucracy inherent to healthcare and medical sectors could slow adoption.
Inefficiencies and waste in the global healthcare system — valued at over $4 trillion annually — underscore the need for innovation. Decentralized approaches may offer solutions, enabling more effective systems and reducing costs. Personal experiences, like the inefficiencies faced during cancer treatment, emphasize the transformative potential of DeSci.
Events like a recent DeSci conference in Korea demonstrate progress, where collaborations with traditional healthcare institutions were forged. Such initiatives aim to educate and integrate conventional players into the DeSci ecosystem. Upcoming conferences planned for 2024 may further these efforts, potentially drawing participation from both the DeSci community and pharma giants.
There is a strong emphasis on fostering collaboration between Web3 innovators and traditional players. The DeSci space needs traditional healthcare’s involvement to scale its impact and drive mainstream adoption, ultimately benefiting patients by reducing healthcare costs and improving outcomes.
Spread: Expressed gratitude for being part of the space and emphasized the passion and effort of the community to improve lives. Highlighted the long-standing contributions of builders in the DeSci sector, suggesting their cumulative efforts led to this moment.
Asher: Believes figures like Brian Armstrong and CZ are genuine in their efforts to push meaningful initiatives in the crypto space. Mentioned that these icons aim to counteract the negative aspects of Web3 (e.g., scams and non-utility projects) by promoting projects with real-world utility and impact.
Justin: Noted Brian Armstrong’s involvement in the DeSci narrative via projects like ResearchHub, albeit without aggressive promotion. CZ has shown sporadic interest, recently investing in bio-related projects like BioXYZ, suggesting behind-the-scenes work on the DeSci narrative.
The Space concluded with collaborative growth and optimism:
Justin: Highlighted the importance of collaborative efforts among DeSci projects to gain more exposure and reach mainstream audiences. Emphasized the non-competitive, community-driven nature of the space.
Spread: Drew an analogy between DeSci and the growth of a bamboo tree — slow but poised for exponential growth after years of nurturing. Expressed admiration for the achievements in DeSci over the past four years, attributing it to collective effort and resilience.
Nathan: Encouraged the audience to engage with their platform, suggesting active participation in DeSci projects as a way to drive the space forward.
The panel discussion lasted for 75 minutes and garnered an impressive 190,000 listeners!
For more updates and to join the conversation, follow BitDoctor on their social media platforms and join the Telegram community. Be a part of the future of healthcare!
We have released our app on:
-Google Play Store: https://play.google.com/store/apps/details?id=com.bitDoctor.ai.android
-Apple App Store: https://apps.apple.com/us/app/bitdoctor-ai/id6738619305
Access BitDoctor AI Doctor for IHB monitoring and track over 30 health parameters right from your smartphone!
BitDoctor is driven by a mission to democratize healthcare access globally. With over 4.5 billion people lacking basic healthcare services, the app aims to close this gap by providing accessible, effective, and secure medical insights through the integration of AI and blockchain technologies.
By fostering a community-driven approach and prioritizing user feedback, BitDoctor is setting a new standard in digital healthcare, making advanced medical resources accessible to all, regardless of geographic or economic barriers.
For more updates and to join the conversation, follow BitDoctor on their social media platforms and join the Telegram community. Be a part of the future of healthcare!
Saving All Lifes, At All Time.
For more information/partnership, email us at: [email protected]
Website https://bitdoctor.ai/
X Twitter https://twitter.com/bitdoctorai
Telegram https://t.me/BitDocAI (Global)
Youtube https://www.youtube.com/@BitDoctorAI
Instagram https://www.instagram.com/bitdoctor.ai/
Asher Loo started his career in event management and later expanded it horizontally into film production, events, and advertising. Serving national clients such as Coca-Cola, Nestle and Ang Lee. He then ventured into real estate and promoted to Project Director and Partner of the firm within a year. Asher has also earned several prestigious awards during his entrepreneurship journey. After reaching his highest point in real estate, Asher ventured into the world of investments, including Cryptocurrencies and Fintech, and since 2019 Asher's mission is now to create a revolutionary programme in the Health and Pharmatech industry to improve quality of life and the wellbeing of mankind.
Mint Your Premium Membership
Download